Table 1.
Characteristic of the study group treated enzymatically using Nexobrid® (NXB).
| Gender | Age | Cause | Depth | Total% | NXB % | Location of NXB | After NXB | STSG | Reconstruction | Length of Stay | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | M | 12 | flame | II/III | 45% | 9% | upper limbs | Skin grafts | yes (early) | no | 38 |
| 2 | F | 5 | flame | II/III | 27% | 27% | trunk, upper limbs | Skin grafts | yes (early) | z-plasty | 77 |
| 3 | F | 3 | scald | II/III | 60% | 20% | lower limbs | Suprathel | no | no | 82 |
| 4 | M | 5 | hot oil | II/III | 39% | 12% | trunk, lower limbs | Suprathel | yes (delayed) | z-plasty | 33 |
| 5 | F | 3 | scald | II/III | 20% | 20% | trunk, upper limbs | Suprathel | yes (delayed) | z-plasty | 25 |
| 6 | M | 15 | flame | II/III | 2% | 2% | upper limb | Jelonet + Gel | no | no | 7 |
| 7 | F | 8 | hot oil | II/III | 7% | 7% | trunk, upper limb | Jelonet + Gel | yes (delayed) | z-plasty | 24 |
| 8 | M | 13 | flame | II/III | 47% | 18% | trunk, limbs | Jelonet + Gel | yes (delayed) | z-plasty | 37 |
| 9 | F | 10 | flame | II/III | 64% | 25% | upper and lower limbs | Jelonet + Gel | yes (delayed) | z-plasty | 28 |
| 10 | M | 12 | flame | II/III | 15% | 15% | trunk, upper limb | skin grafts | yes (early) | no | 29 |
| 11 | M | 9 | scald | II/III | 15% | 15% | trunk, limbs | Suprathel | yes (delayed) | z-plasty | 35 |
| 12 | F | 7 | contact | II/III | 7% | 7% | upper limb | Mepithel | no | no | 8 |